It is currently Mon Sep 26, 2016 1:50 pm

News News of General Discussion

Site map of General Discussion » Forum : General Discussion

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

MS treatments 'may lower white cell levels'

Multiple sclerosis patients are at risk of developing lymphopenia, or abnormally low levels of immune defense white blood cells, called lymphocytes, according to a new study...Read more - http://www.ms-uk.org/ms-treatments-may-lower-white-cell-levels-020916
Read more : MS treatments 'may lower white cell levels' | Views : 285 | Replies : 2


Lifestyle ‘may impact on MS disability’

A new study claims a healthier lifestyle is strongly associated with lower chances of an MS patient having mobility issues...Read more - http://www.ms-uk.org/lifestyle-%E2%80%98may-impact-ms-disability%E2%80%99-010916
Read more : Lifestyle ‘may impact on MS disability’ | Views : 244 | Replies : 0


Misdiagnosis revealed in new study

A number of common conditions are mistaken for multiple sclerosis say researchers at four academic medical centres across the U.S. in a study published in the journal Neurology...Read more - http://www.ms-uk.org/misdiagnosis-revealed-new-study-010916
Read more : Misdiagnosis revealed in new study | Views : 353 | Replies : 5


Juicing raw cannabis

Hi all,

I came across ingesting (e.g. by juicing) raw cannabis a while ago, and I found it intriguing. As I understand it, by consuming it raw, THCA will not be converted to THC and therefore you won't have any psychoactive effects. In turn, this should allow you to easily take in much more of the cannabinoids in the plant which would be beneficial to one's health.

A few pages with some info are:
    ...
Read more : Juicing raw cannabis | Views : 347 | Replies : 3


Study suggests hemoglobin variant may reduce MS severity

Multiple sclerosis seems to be less severe in people with higher levels of the minor adult hemoglobin variant A2 (HbA2) in their blood, possibly because this variant works to protect and stabilize the membrane of red blood cells, according to researchers in Turkey...Read more - http://www.ms-uk.org/study-suggests-hemoglobin-variant-may-reduce-ms-severity-260816
Read more : Study suggests hemoglobin variant may reduce MS severity | Views : 288 | Replies : 0


Amiselimod study shows ‘promising results’

New research has found that Amiselimod “significantly” reduces the number of MS-related lesions found in various brain areas...Read more - http://www.ms-uk.org/amiselimod-study-shows-%E2%80%98promising-results%E2%80%99-250816
Read more : Amiselimod study shows ‘promising results’ | Views : 303 | Replies : 0


Novartis announces positive results for Siponimod

Novartis AG has said that a late-stage study has shown the oral, once-daily BAF312 drug, or Siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis...Read more - http://www.ms-uk.org/novartis-announces-positive-results-siponimod-250816
Read more : Novartis announces positive results for Siponimod | Views : 275 | Replies : 0


should CIS be considered MS?

Should CIS be considered MS? If we assume that MS is the presence of multiple scars, just one lesion should not be considered MS.

On the other hand, normally MS refers the underlying condition that produces the scars. From this point of view CIS should be inside MS when is expected to evolve into clinical MS.

What do you think? What should be the proper way to classify CIS?
Read more : should CIS be considered MS? | Views : 318 | Replies : 0


THERE IS NO MONEY IN THE CURE!

Day after day, I read through MS chat rooms, to find something that would give me hope...but it has been over 20 Years that I have had MS, and the truth is that NOTHING works and that NOTHING new has been developed. I am still on the some interferon, not because it works, but because it is profitable for drug companies. Furthermore, it is highly profitable for the Government too, as they get to tax ...
Read more : THERE IS NO MONEY IN THE CURE! | Views : 840 | Replies : 19


The story of Rituxan and the weakest point in the system

Maybe some of you have heard about the history of Rituxan and Ocrelizumab. Ocrelizumab is a slightly modified version of Rituxan/Rituximab. As Rituxan was approaching FDA approval for treatment of multiple sclerosis (with very good results), it was also approaching the end of its patent. Therefore the company decided that it was not profitable to pursue the approval process for a treatment that would be available soon from other productors.

The history is explained by ...
Read more : The story of Rituxan and the weakest point in the system | Views : 457 | Replies : 5


 

Login  •  Register


Statistics

Total posts 234251 • Total topics 25185 • Total members 16406


Contact us | Terms of Service